Keys to create new technology-based companies

PHOTO: Manuel Castells

With the sponsorship of Enterprise Europe Network and the Chair Bancaja Young Entrepreneurs, the high school Scientific and Technological of the University of Navarra (ICT), together with the Foundation business-University of Navarra, (FEUN) has organized a series of talks on issues core topic to create new technology-based companies.

This cycle consists of five sessions. The first one, at position by Juan José Güemes, president of the International Center for Entrepreneurial management , will take place next Thursday 17th at degree scroll "Creation of technology-based companies" and will be held at auditorium del CIMA.

The following week, on February 24, Angel Sanchez, physicist at training and director of I-deals - a spin-off of the Everis consulting firm - will address the question "How much is my research worth?". His business, I-deals, selects technological innovations, values them, attracts funds and/or partners and, finally, defines the process for their commercialization in those cases where it is possible. Since the beginning of 2010, it has also been collaborating with the ICT in the valorization process of the technologies of the University of Navarra.

Mathieu Carenzo - in charge of the third session on March 9 - is director of the Center for Entrepreneurship at IESE Business School, University of Navarra. Specializing in advising spin-offs and entrepreneurs, Carenzo will talk about relevant aspects of financing a business.

Ricardo Pérez Merino, an economist at the University and director general manager of the venture capital management company core topic Mayor, will attend the cycle as an expert in the assessment of business proposals. Thus, on March 16, he will explain how to make a business plan as if it were a road map, instead of a plan that only endorses the economic viability of an idea.

Finally, Joan Ballesteros -president and director scientist of Vivia Biotech. graduate in Chemical Sciences from the University of Barcelona and PhD in Biomedicine from the Mount Sinai School of Medicine of the University of New York- will close the cycle on March 29th. In his session, Ballesteros will talk about his career as partner founder and chief scientific officer of the company Novasite Pharmaceuticals, in San Diego (California). An experience after which he started Vivia in 2007, with a venture capital base of four million euros.